🎉 Pharmidex Celebrates Scientific Achievement! 🧪
January 27, 2025

We are thrilled to announce that members of the  Pharmidex  team have contributed to groundbreaking research, published in the prestigious journal  International Journal of Molecular Sciences


📄 The paper, titled "Biomass-Derived Nanoporous Carbon Honeycomb Monoliths for Environmental Lipopolysaccharide Adsorption from Aqueous Media", explores innovative solutions for environmental challenges using advanced materials science.


👏 We extend our heartfelt congratulations and gratitude to all the authors for their dedication and hard work in bringing this important research to life.


🔗 Curious about the study? You can read the full article here: Read the Article (https://www.mdpi.com/1422-0067/26/3/952#)

We are proud to support and celebrate cutting-edge science that drives meaningful impact. Let’s continue pushing the boundaries of innovation! 🚀

#Pharmidex #Research #Innovation #Nanotechnology #Sustainability #Science

Ian Knowles will be attending the Drug Delivery to the Lungs Conference

December 8, 2025
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.

Pharmidex at "Recent Clinical Candidates and SMR Award Meeting"

December 3, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!

Pharmidex will attend Genesis 2025 hosted by One Nucleus

December 2, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
More Posts